Ximedica and KeborMed announced today that they have entered into a partnership to offer Ximedica customers a turnkey connectivity solution for medical devices.
Online PR News – 21-July-2020 – PROVIDENCE, RI and CLEVELAND, OH – Ximedica and KeborMed announced today that they have entered into a partnership to offer Ximedica customers a new and complete turnkey solution to launching and supporting connected medical devices, in a streamlined, faster and more affordable manner.
“We are excited to partner with KeborMed to enhance our capabilities in the development of connected medical solutions,” said Michael Pereira, President and COO of Ximedica. “We are seeing enormous demand from our clients for the rapid implementation of connected medical devices, particularly as a result of the Covid-19 pandemic dramatically accelerating the development of telehealth and remote patient monitoring solutions. Adding KeborMed’s capabilities to our offering will significantly change how fast we can move from prototype to a fully deployed connected medical solution.”
KeborMed provides a novel approach to developing, scaling and maintaining regulatory-compliant connected medical devices. KeborMed’s Connected Care Platform takes a plug-n-play approach, replacing custom development with a turnkey solution, while drastically reducing the cost and time to market traditionally associated with the development of connected medical solutions.
“Our partnership with Ximedica, a global leader in medical device design and development is an incredibly exciting opportunity,” said Radu Iancu, CEO of KeborMed. “Cloud connectivity is a must-have for modern remote care solutions, and the KeborMed PaaS provides all the components for any device manufacturer to become an integrated solution provider in record time, regardless of the medical space they are in. Through our partnership with Ximedica, we are looking forward to bringing a significant contribution to how healthcare is delivered, with the ultimate goal of improving patient outcomes and reducing the financial strain on medical systems.”
Ximedica intends to leverage KeborMed’s cloud agnostic platform to add connectivity to a range of internal and external projects across medical specialties from respiratory to surgical.
Ximedica is a full-service ISO 13485 certified and FDA-registered medical device and diagnostics product development firm. For 30 years Ximedica has provided a unique growth platform enabling organizations to successfully deploy medical technology products into the market. Its headquarters are in Providence, RI, with offices in Hong Kong, Minneapolis, Philadelphia and San Francisco.. In November of 2014, SV LifeSciences, a Boston-based private equity firm, acquired a majority stake in Ximedica, enabling the company to execute its growth strategy. For more about Ximedica, visit https://www.ximedica.com.
KeborMed is the first plug-n-play PaaS for connected medical devices, ready to provide medical device companies with all necessary components to develop, validate and deploy a cloud-connected medical solution. The KeborMed platform can reduce time to market and the costs associated with adding, or enhancing, connectivity to medical devices by up to 90%, providing medical device companies with an immediate competitive edge. Its headquarters are in Cleveland, Ohio, with development resources in Romania and Portugal. For more about KeborMed, visit https://www.kebormed.com.